Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Steroid Failure At Day 28 After Acute Graft-Versus-Host Disease Treatment and Long-Term Outcomes Following Allogeneic Transplantation: Adverse Impact On Survival and Non-Relapse Mortality But No Increasing Risk Of Relapse

Joon Ho Moon, M.D., Ph.D., Sang Kyun Sohn, MD, PhD, Naheed Alam, MBBS, Jieun Uhm, MD, Vikas Gupta, MD, FRCP, FRCPath, Jeffrey H. Lipton, MD, PhD, Hans A. Messner, M.D./Ph.D, John Kuruvilla, MD, FRCPC, Dennis Dong Hwan Kim, MD, PhD

Blood (2013) 122 (21): 2066.

https://doi.org/10.1182/blood.V122.21.2066.2066

Published: 2013

Journal Articles

Role Of Hypomethylating Agents For Patients With Lower-Risk Myelodysplastic Syndrome Defined By IPSS and IPSS-R

Joon Ho Moon, M.D., Ph.D, Sang Kyun Sohn, MD, PhD, Jae Sook Ahn, MD, Yeo-Kyeoung Kim, MD, PhD, Hyeoung Joon Kim, MD, PhD, Moo-Kon Song, MD, Ho-Jin Shin, Joo-Seop Chung, MD, PhD, Ik Chan Song, MD, Deog-Yeon Jo, MD, PhD, Sung Nam Lim, MD, Ho Sup Lee, Yang Soo Kim, MD, PhD, Sung Hwa Bae

Blood (2013) 122 (21): 2782.

https://doi.org/10.1182/blood.V122.21.2782.2782

Published: 2013

Journal Articles

Prognostic Significance Of Systemic Inflammatory Factors In Patients With Diffuse Large B Cell Lymphoma Treated By R-CHOP

Kyung Ah Yoh, Ho Sup Lee, Lee Chun Park, MD, Eun Mi Lee, Seong Hoon Shin, MD, Byeong Jin Ye, Joon Ho Moon, M.D., Ph.D., Jae-Cheol Jo, Won Sik Lee, M.D., Ho-Jin Shin, Sun Young Oh, MD, Yang Soo Kim

Blood (2013) 122 (21): 1802.

https://doi.org/10.1182/blood.V122.21.1802.1802

Published: 2013

Journal Articles

Predictive Factors for Rapid Engraftment of Neutrophil and Platelet After Allogenic Peripheral Blood Stem Cell Transplantation in Patients with Hematologic Malignancies

Ho Sup Lee, MD, Lee Chun Park, MD, Eun Mi Lee, Byeong Jin Ye, MD, Joon Ho Moon, M.D., Won Sik Lee, Ho-Jin Shin, Jooseop Chung, MD, PhD, Yang Soo Kim

Blood (2012) 120 (21): 4499.

https://doi.org/10.1182/blood.V120.21.4499.4499

Published: 2012

Journal Articles

Comparative Analysis of Outcomes of Allogeneic Peripheral Blood Stem Cell Transplantation From Related and Unrelated Donors.

Byung Woog Kang, M.D., Shi Nae Kim, M.D., Joon Ho Moon, M.D., Joo-Seop Jung, Goon-Jae Cho, Deog Yeon Jo, Yeo-Kyeoung Kim, Hyeoung Joon Kim, MD, Hun-Mo Ryoo, Hyeon Seok Eom, MD, PhD, Sang Min Lee, Young-Don Joo, Jong Ho Won, Moo-Rim Park, MD, Min Kyoung Kim, Myung Soo Hyun, MD, PhD, Sang Kyun Sohn, M.D.

Blood (2009) 114 (22): 3381.

https://doi.org/10.1182/blood.V114.22.3381.3381

Published: 2009

Journal Articles

Clinical Implications of Pulmonary Function Tests in Allogeneic Stem Cell Recipients.

Joon Ho Moon, M.D., Byung Woog Kang, M.D., Shi Nae Kim, M.D., Soo Jung Lee, M.D., Yun Jeong Kim, M.D., Jang Soo Suh, M.D., Kun Soo Lee, M.D., Yoon Young Cho, M.D., Jae Hoo Park, M.D., Sang Kyun Sohn, M.D.

Blood (2009) 114 (22): 4297.

https://doi.org/10.1182/blood.V114.22.4297.4297

Published: 2009

Journal Articles

Favorable Transplantation Outcomes Associated with Early Recovery of Lymphocytes and CD8+ Cells Following Allogeneic Stem Cell Transplantation.

Joon Ho Moon, M.D., Yoon Young Cho, M.D., Byung Woog Kang, M.D., Shi Nae Kim, M.D., Soo Jung Lee, M.D., Yun Jeong Kim, M.D., Jang Soo Suh, M.D., Kun Soo Lee, M.D., Jae Hoo Park, M.D., Sang Kyun Sohn, M.D.

Blood (2009) 114 (22): 4665.

https://doi.org/10.1182/blood.V114.22.4665.4665

Published: 2009

Journal Articles

Infectious Complications in Asian Patients Treated with Alemtuzumab: Results From a Multicenter Study.

Seok Jin Kim, MD, PhD, Ary Harryanto Reksodiputro, Ann-Lii Cheng, Tanin Intragumtornchai, MD, Surapol Issaragrisil, MD, Joon Ho Moon, M.D., Jin Seok Kim, M.D., Ph.D., Je-Jung Lee, Jong Ho Won, Won Seog Kim, Yok Lam Kwong, MD

Blood (2009) 114 (22): 5009.

https://doi.org/10.1182/blood.V114.22.5009.5009

Published: 2009

Journal Articles

BCL2 Gene Polymorphism Could Predict the Treatment Outcomes in Patients with De Novo Acute Myeloid Leukemia

Kyoung Ha Kim, M.D., Dong Hwan Kim, MD, PhD, Su Jin Lee, M.D., Joon Ho Moon, M.D., Myung Hee Chang, M.D., Myung Hoon Lee, PhD, Chul Won Jung, M.D./Ph.D., Sang Kyun Sohn, M.D./Ph.D.

Blood (2008) 112 (11): 3973.

https://doi.org/10.1182/blood.V112.11.3973.3973

Published: 2008

Journal Articles

The Mobilization Effects of G-CSF, GM-CSF and Darbepoetin-α for Allogeneic Peripheral Blood Stem Cell Transplantation.

Shi Nae Kim, MD, Sang Kyun Sohn, M.D., Jong Gwang Kim, M.D., Yee Soo Kim, M.D., Yoon Young Cho, M.D., Joon Ho Moon, M.D., Byung Min Ahn, M.D., Soo Jung Lee, M.D., Yun Jeong Kim, M.D.

Blood (2007) 110 (11): 4932.

https://doi.org/10.1182/blood.V110.11.4932.4932

Published: 2007

Journal Articles

Early Onset of Acute Graft-Versus-Host Disease Indicating a Worse Prognosis in Terms of Chronic Graft-Versus-Host Disease and Survival Compared to Late Onset.

Sang Kyun Sohn, MD, Joon Ho Moon, M.D., Jong Gwang Kim, M.D., Yee Soo Chae, M.D., Yoon Young Cho, M.D., Byung Min Ahn, M.D., Shi Nae Kim, M.D., Soo Jung Lee, M.D., Yun Jeong Kim, M.D.

Blood (2007) 110 (11): 4979.

https://doi.org/10.1182/blood.V110.11.4979.4979

Published: 2007

Journal Articles

The Impact of Alemtuzumab as a Component of Conditioning Regimens on Transplantation Outcomes in a Setting of CMV-Seropositive Recipient and Donor.

Byung Min Ahn, MD, Sang Kyun Sohn, M.D., Jong Kwang Kim, M.D., Yee Soo Chae, M.D., Yoon Young Cho, M.D., Joon Ho Moon, M.D., Deok Hwan Yang, M.D., Je-Jung Lee, M.D., Yeo-Kyeoung Kim, M.D., Hyeoung-Joon Kim, M.D.

Blood (2006) 108 (11): 5270.

https://doi.org/10.1182/blood.V108.11.5270.5270

Published: 2006

Journal Articles

Risk Factors for Predicting CMV Infection in Allogeneic-PBSCT Setting: MNC Dose, Campath Use, and Acute GVHD Grade ≥II.

Byung Min Ahn, MD, Joon Ho Moon, M.D., Yoon Young Cho, M.D., Yee Soo Chae, M.D., Jong Gwang Kim, M.D., Sang Kyun Sohn, M.D.

Blood (2006) 108 (11): 5298.

https://doi.org/10.1182/blood.V108.11.5298.5298

Published: 2006

NARROW

Steroid Failure At Day 28 After Acute Graft-Versus-Host Disease Treatment and Long-Term Outcomes Following Allogeneic Transplantation: Adverse Impact On Survival and Non-Relapse Mortality But No Increasing Risk Of Relapse

Role Of Hypomethylating Agents For Patients With Lower-Risk Myelodysplastic Syndrome Defined By IPSS and IPSS-R

Prognostic Significance Of Systemic Inflammatory Factors In Patients With Diffuse Large B Cell Lymphoma Treated By R-CHOP

Predictive Factors for Rapid Engraftment of Neutrophil and Platelet After Allogenic Peripheral Blood Stem Cell Transplantation in Patients with Hematologic Malignancies

Comparative Analysis of Outcomes of Allogeneic Peripheral Blood Stem Cell Transplantation From Related and Unrelated Donors.

Clinical Implications of Pulmonary Function Tests in Allogeneic Stem Cell Recipients.

Favorable Transplantation Outcomes Associated with Early Recovery of Lymphocytes and CD8+ Cells Following Allogeneic Stem Cell Transplantation.

Infectious Complications in Asian Patients Treated with Alemtuzumab: Results From a Multicenter Study.

BCL2 Gene Polymorphism Could Predict the Treatment Outcomes in Patients with De Novo Acute Myeloid Leukemia

The Mobilization Effects of G-CSF, GM-CSF and Darbepoetin-α for Allogeneic Peripheral Blood Stem Cell Transplantation.

Early Onset of Acute Graft-Versus-Host Disease Indicating a Worse Prognosis in Terms of Chronic Graft-Versus-Host Disease and Survival Compared to Late Onset.

The Impact of Alemtuzumab as a Component of Conditioning Regimens on Transplantation Outcomes in a Setting of CMV-Seropositive Recipient and Donor.

Risk Factors for Predicting CMV Infection in Allogeneic-PBSCT Setting: MNC Dose, Campath Use, and Acute GVHD Grade ≥II.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only